November 23, 2015
Pfizer and Allergan in $160B merger
Pfizer and Allergan have entered into a definitive merger agreement under which Pfizer will combine with Allergan in a transaction valued at about $160 billion.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
November 23, 2015
Pfizer’s ex man joins Vertex as Vice President and Chief Legal Officer
Vertex Pharmaceuticals, a biotechnology company has appointed Pfizer’s Senior Vice president Michael J. Parini to the role of Executive Vice President and Chief Legal Officer.
November 23, 2015
India’s Aurobindo gets USFDA’s OK for its pulmonary tablets ‘Sildenafil’
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil…
November 23, 2015
Green light in EU for Novartis’ Cosentyx
The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS.
November 23, 2015
Geistlich Pharma recalls Decalcit chewing tablets due to Italian version typo
The Swiss-based company Geistlich Pharma AG is recalling batch of Decalcit, vitamin D and calcium chewable tablets, from the market.
November 20, 2015
Bayer submits its new five-year-contraceptive for EU and US marketing Authorization
Bayer has submitted an application for marketing authorization in both the European Union and in the United States for LCS-16, a new low-dose levonorgestrel-releasing intrauterine system
November 20, 2015
Sanofi and AstraZeneca to share compound libraries
Sanofi and AstraZeneca have announced a direct exchange of 210,000 compounds from their respective, proprietary compound libraries.
November 20, 2015
Mylan in patent lawsuit
Mylan’s subsidiaries were sued Warner Chilcott and Qualicaps in connection with the filing of an ANDA with the FDA for Mesalamine Delayed-release Capsules.
November 20, 2015
Clozapine REMS deadlines for prescribers and pharmacies extended
The prescriber certification deadline for new Clozapine REMS Program has been extended from November 23 to December 14. Due to…
November 20, 2015
FDA advices not to use XForMan Plus
The Food and Drug Administration (FDA) has issued a notice in which it advises consumers not to purchase or use XForMan Plus,…